BEAM vs WRK
Beam Therapeutics Inc (BEAM) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
WRK (WRK) common stock.
Latest reported BEAM revenue for 2026-06-30 was $32.2M. Net income was -$217.0M. Revenue was up 1.5% from 2026-03-31 to 2026-06-30. BEAM currently screens at market cap $2.01B.
WRK does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B.
Not investment advice. Open the BEAM and WRK stock pages for the full models.
Not investment advice.